Contact Us
 • 
Home
Search 

 
Read more about the Liverpool CTU

 
 
CRUK Liverpool Cancer Trials Unit
CRUK Liverpool
Cancer Trials Unit

 
North West Surgical Trials Centre
North West Surgical
Trials Centre

 
NIHR HTA Division
NIHR HTA
Division

 
Marie Curie Cancer Care
Marie Curie
Cancer Care

 
Liverpool Early Drug Development Unit
Liverpool Early Drug
Development Unit
LCTU GCLP Laboratories
LCTU GCP
Laboratories

Other Funding
Associations
Liverpool CTU Senior Management Team
Liverpool CTU Senior
Management Team



 

The LCTU receives Core Support Funding from Cancer Research UK (CRUK), The National Institute for Health Research (NIHR) and the Royal Collage of Surgeons of England.
 



Latest News

New approach improves five-year survival for pancreatic cancer patients

A University of Liverpool led clinical trial has shown that 29% of pancreatic cancer patients given a combination of two chemotherapy drugs lived for at least five years compared with 16% who received the one chemotherapy drug.

The latest Cancer Research UK figures show that around 9,400 people are diagnosed with pancreatic cancer each year in the UK and around 8,800 people die from the disease each year.

The trial involved 732 patients in hospitals across the UK, German, Sweden .....

Liverpool Scientists Set To Get Million Pound Cash Boost For Cancer Research

LIVERPOOL scientists and doctors are set to receive a major cash boost for research into cancer.

Leading research charity Cancer Research UK and the National Institute for Health Research (NIHR) plan to invest nearly £1.5m over the next five years into ground-breaking work at the Liverpool Experimental Cancer Medicine Centre (ECMC)*.

In Liverpool, the ECMC is a collaboration between The Clatterbridge Cancer Centre NHS Foundation Trust, the Cancer Research UK Liverpool .....

Saver Launch

Launch of SAVER, an NIHR EME funded oral cancer prevention study

Professor Richard Shaw’s NIHR EME funded Sodium Valproate for the Epigenetic Reprogramming of High-Risk Oral Epithelial Dysplasia (SAVER) trial, investigating the role of Sodium Valproate in chemoprevention of Oral Squamous Cell Carcinoma (OSCC), had a very successful launch event on 29th November ’16. The day also provided a clinical update opportunity for the management of Oral Epithelial Dysplasis (OED). Presentation topics included the management of OED, Allelic Imbalance and .....

ECMC

£226 million UK investment in cancer research announced

Cancer Research UK has announced the largest investment to date into its network of Centres across the UK. £190 million has been committed to 13 Cancer Research UK Centres over the next five years. The huge investment will draw together world class research and medical expertise to accelerate advances in research and support clinical trials essential to getting lifesaving treatments to patients.